Human Vaccines Global Market Report 2021 - COVID-19 Growth and Change

  • Published On: Jul, 2020
  • Category: Healthcare
  • Pages: 190
The global Human Vaccine market size is estimated at 115.2 billion USD with a CAGR of 10.3% during the forecasted period from 2021-2028.

Global Human Vaccines Market Overview

The global Human Vaccine market size is estimated at 115.2 billion USD with a CAGR of 10.3% during the forecasted period from 2021-2028. The key factor that drives the growth of global Human Vaccine market is attributed to increasing occurrence of diseases. In addition, government all over the world are taking initiatives to reduce the disease burden which positively impacts the market size. Moreover, significant rise in vaccine research & developments activities is fostering the market. Also, the current COVID-19 pandemic is playing a crucial role to influence the human vaccine market. The developing nations are projected to offer substantial growth opportunities to Human Vaccine market. This can be attributed to lack of awareness about the causative agents of disease and less significance of sanitation & hygiene issues. Conversely, increase in disposable income and augmented expenditure on healthcare in developed nations uplift the growth of this market. On the other hand, high vaccine prices and uncertain time required for vaccine development may restrict the Human Vaccine market. The Global Human Vaccines Market report is a precise and deep-dive study on the current state that aims at the major drivers, market strategies, and imposing growth of the key players. Worldwide Human Vaccines Industry also offers a granular study of the dynamics, segmentation, revenue, share forecasts, and allows you to make superior business decisions. The report serves imperative statistics on the market stature of the prominent manufacturers and is an important source of guidance and advice for companies and individuals involved in the Human Vaccines industry. Impact of Coronavirus (COVID-19) on Global Human Vaccines Market. Coronavirus (COVID-19) is spreading across the world with a serious impact on the economy and the global market. The report considers and accounts for the impact of COVID-19 on Global Human Vaccines Market across all the segments, regions, countries, and key players. North America and Europe are worst-hit countries by Coronavirus which are key players in the global economy. The report provides a detailed analysis of the impact on the market, growth strategies, supply china disruption, consumption pattern of the Global Human Vaccines Market.

Market Segmentation

The report provides market size with 2019 as the base year in consideration and a yearly forecast until 2026 in terms of Revenue (USD Million). The estimates for all segments including type and application have been provided on a regional basis for the forecast period mentioned above. We have implemented a mix of top-down and bottom-up approaches for market sizing, analyzing the key regional markets, dynamics, and trends for various applications. Global Human Vaccines Market by Key Segments: Global human Vaccines Market, by Vaccine Type
  • Conjugate
  • Recombinant
  • Inactivated
  • Combination
  • Attenuated
  • Others
Global Human Vaccines Market, by Product
  • Pneumococcal
  • Influenza
  • Hepatitis
  • HPV
  • Meningococcal
  • Rotavirus
  • Measles and Mumps
  • Typhoid
  • Combination
  • Others
Global Human Vaccines Market, by Age Group
  • Pediatrics
  • Adolescents
  • Adults
  • Geriatrics
Global Human Vaccines Market, by Distribution Channel
  • Hospital Pharmacies
  • Drugstores
  • Others
Competitive Landscape: Key players profile in the report include
  • AstraZeneca
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Pfizer, Inc.
  • Sanofi
  • Johnson & Johnson
The report of Global Human Vaccines Market studies the key players present in the market. The chapter includes the competitive landscape section which provides the full and in-depth analysis of the current market trends, changing technologies, and developments that will be beneficial for the companies, which are competing in the market. The report offers an overview of revenue, demand, and supply of data, futuristic cost, and growth analysis during the projected year. In addition to a brief overview of the company, analysts shed light on their valuation and evolution. It also discusses the list of important products and the ones in the pipeline. The competitive landscape is analyzed by understanding the approaches of the companies and the initiatives they have taken in recent years to triumph over the intensive competition.

Regional Analysis

By Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Mexico
    • Rest of South America
  • Middle East & Africa
    • GCC Countries
    • Africa
    • Rest of Middle East
Frequently Asked Questions (FAQ):
  • What is the size of the Global Human Vaccines Market?
  • How much will this market be worth from 2020 to 2030?
  • What are the major deals happenings in the Global Human Vaccines Market?
  • Which country is expected to hold the highest market share in the Global Human Vaccines Market?
  • What are production processes, major issues, and solutions to mitigate the development risk?
  • Who are the top players and what are their activities, revenue, recent developments, and prospects?
  • What are the main drivers and restraints in the Global Human Vaccines Market?
  • Which are the largest revenue generating products, services or regions and their comparative growth rate?

Table of Contents 1 Market Overview 1.1 Human Vaccines Introduction 1.2 Market Analysis by Type 1.2.1 Varicella 1.2.2 Influenza 1.2.3 Polio 1.2.4 Hepatitis A 1.2.5 Rabies 1.2.6 BCG 1.2.7 Hepatitis B 1.2.8 Other 1.3 Market Analysis by Applications 1.3.1 Adults 1.3.2 Children 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2030) 1.4.1.2 Canada Market States and Outlook (2014-2030) 1.4.1.3 Mexico Market States and Outlook (2014-2030) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2030) 1.4.2.2 France Market States and Outlook (2014-2030) 1.4.2.3 UK Market States and Outlook (2014-2030) 1.4.2.4 Russia Market States and Outlook (2014-2030) 1.4.2.5 Italy Market States and Outlook (2014-2030) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2030) 1.4.3.2 Japan Market States and Outlook (2014-2030) 1.4.3.3 Korea Market States and Outlook (2014-2030) 1.4.3.4 India Market States and Outlook (2014-2030) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2030) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2030) 1.4.4.2 Egypt Market States and Outlook (2014-2030) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2030) 1.4.4.4 South Africa Market States and Outlook (2014-2030) 1.4.4.5 Turkey Market States and Outlook (2014-2030) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 CNBG 2.1.1 Business Overview 2.1.2 Human Vaccines Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 CNBG Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Changsheng Life 2.2.1 Business Overview 2.2.2 Human Vaccines Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Changsheng Life Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 Zhifei 2.3.1 Business Overview 2.3.2 Human Vaccines Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Zhifei Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 ChengDa Bio 2.4.1 Business Overview 2.4.2 Human Vaccines Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 ChengDa Bio Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Kangtai 2.5.1 Business Overview 2.5.2 Human Vaccines Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Kangtai Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 SINOVAC BIOTECH 2.6.1 Business Overview 2.6.2 Human Vaccines Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 SINOVAC BIOTECH Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 Hissen 2.7.1 Business Overview 2.7.2 Human Vaccines Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Hissen Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 Walvax Biotechnology 2.8.1 Business Overview 2.8.2 Human Vaccines Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Walvax Biotechnology Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 GSK 2.9.1 Business Overview 2.9.2 Human Vaccines Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 GSK Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.10 SANOFI 2.10.1 Business Overview 2.10.2 Human Vaccines Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 SANOFI Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.11 Rong An 2.11.1 Business Overview 2.11.2 Human Vaccines Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Rong An Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.12 NuoCheng Bio 2.12.1 Business Overview 2.12.2 Human Vaccines Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 NuoCheng Bio Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.13 Hualan Bio 2.13.1 Business Overview 2.13.2 Human Vaccines Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Hualan Bio Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.14 Tiantan biological 2.14.1 Business Overview 2.14.2 Human Vaccines Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Tiantan biological Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.15 Changchun Baike 2.15.1 Business Overview 2.15.2 Human Vaccines Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Changchun Baike Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.16 Adimmune 2.16.1 Business Overview 2.16.2 Human Vaccines Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Adimmune Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.17 Zhongyianke Biotech 2.17.1 Business Overview 2.17.2 Human Vaccines Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Zhongyianke Biotech Human Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Human Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Human Vaccines Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Human Vaccines Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Human Vaccines Manufacturer Market Share in 2018 3.3.2 Top 6 Human Vaccines Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Human Vaccines Market Analysis by Regions 4.1 Global Human Vaccines Sales, Revenue and Market Share by Regions 4.1.1 Global Human Vaccines Sales and Market Share by Regions (2014-2019) 4.1.2 Global Human Vaccines Revenue and Market Share by Regions (2014-2019) 4.2 North America Human Vaccines Sales and Growth Rate (2014-2019) 4.3 Europe Human Vaccines Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Human Vaccines Sales and Growth Rate (2014-2019) 4.5 South America Human Vaccines Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Human Vaccines Sales and Growth Rate (2014-2019) 5 North America Human Vaccines by Country 5.1 North America Human Vaccines Sales, Revenue and Market Share by Country 5.1.1 North America Human Vaccines Sales and Market Share by Country (2014-2019) 5.1.2 North America Human Vaccines Revenue and Market Share by Country (2014-2019) 5.2 United States Human Vaccines Sales and Growth Rate (2014-2019) 5.3 Canada Human Vaccines Sales and Growth Rate (2014-2019) 5.4 Mexico Human Vaccines Sales and Growth Rate (2014-2019) 6 Europe Human Vaccines by Country 6.1 Europe Human Vaccines Sales, Revenue and Market Share by Country 6.1.1 Europe Human Vaccines Sales and Market Share by Country (2014-2019) 6.1.2 Europe Human Vaccines Revenue and Market Share by Country (2014-2019) 6.2 Germany Human Vaccines Sales and Growth Rate (2014-2019) 6.3 UK Human Vaccines Sales and Growth Rate (2014-2019) 6.4 France Human Vaccines Sales and Growth Rate (2014-2019) 6.5 Russia Human Vaccines Sales and Growth Rate (2014-2019) 6.6 Italy Human Vaccines Sales and Growth Rate (2014-2019) 7 Asia-Pacific Human Vaccines by Country 7.1 Asia-Pacific Human Vaccines Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Human Vaccines Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Human Vaccines Revenue and Market Share by Country (2014-2019) 7.2 China Human Vaccines Sales and Growth Rate (2014-2019) 7.3 Japan Human Vaccines Sales and Growth Rate (2014-2019) 7.4 Korea Human Vaccines Sales and Growth Rate (2014-2019) 7.5 India Human Vaccines Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Human Vaccines Sales and Growth Rate (2014-2019) 8 South America Human Vaccines by Country 8.1 South America Human Vaccines Sales, Revenue and Market Share by Country 8.1.1 South America Human Vaccines Sales and Market Share by Country (2014-2019) 8.1.2 South America Human Vaccines Revenue and Market Share by Country (2014-2019) 8.2 Brazil Human Vaccines Sales and Growth Rate (2014-2019) 8.3 Argentina Human Vaccines Sales and Growth Rate (2014-2019) 8.4 Colombia Human Vaccines Sales and Growth Rate (2014-2019) 9 Middle East and Africa Human Vaccines by Countries 9.1 Middle East and Africa Human Vaccines Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Human Vaccines Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Human Vaccines Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Human Vaccines Sales and Growth Rate (2014-2019) 9.3 Turkey Human Vaccines Sales and Growth Rate (2014-2019) 9.4 Egypt Human Vaccines Sales and Growth Rate (2014-2019) 9.5 Nigeria Human Vaccines Sales and Growth Rate (2014-2019) 9.6 South Africa Human Vaccines Sales and Growth Rate (2014-2019) 10 Global Human Vaccines Market Segment by Type 10.1 Global Human Vaccines Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Human Vaccines Sales and Market Share by Type (2014-2019) 10.1.2 Global Human Vaccines Revenue and Market Share by Type (2014-2019) 10.2 Varicella Sales Growth and Price 10.2.1 Global Varicella Sales Growth (2014-2019) 10.2.2 Global Varicella Price (2014-2019) 10.3 Influenza Sales Growth and Price 10.3.1 Global Influenza Sales Growth (2014-2019) 10.3.2 Global Influenza Price (2014-2019) 10.4 Polio Sales Growth and Price 10.4.1 Global Polio Sales Growth (2014-2019) 10.4.2 Global Polio Price (2014-2019) 10.5 Hepatitis A Sales Growth and Price 10.5.1 Global Hepatitis A Sales Growth (2014-2019) 10.5.2 Global Hepatitis A Price (2014-2019) 10.6 Rabies Sales Growth and Price 10.6.1 Global Rabies Sales Growth (2014-2019) 10.6.2 Global Rabies Price (2014-2019) 10.7 BCG Sales Growth and Price 10.7.1 Global BCG Sales Growth (2014-2019) 10.7.2 Global BCG Price (2014-2019) 10.8 Hepatitis B Sales Growth and Price 10.8.1 Global Hepatitis B Sales Growth (2014-2019) 10.8.2 Global Hepatitis B Price (2014-2019) 10.9 Other Sales Growth and Price 10.9.1 Global Other Sales Growth (2014-2019) 10.9.2 Global Other Price (2014-2019) 11 Global Human Vaccines Market Segment by Application 11.1 Global Human Vaccines Sales Market Share by Application (2014-2019) 11.2 Adults Sales Growth (2014-2019) 11.3 Children Sales Growth (2014-2019) 12 Human Vaccines Market Forecast (2019-2030) 12.1 Global Human Vaccines Sales, Revenue and Growth Rate (2019-2030) 12.2 Human Vaccines Market Forecast by Regions (2019-2030) 12.2.1 North America Human Vaccines Market Forecast (2019-2030) 12.2.2 Europe Human Vaccines Market Forecast (2019-2030) 12.2.3 Asia-Pacific Human Vaccines Market Forecast (2019-2030) 12.2.4 South America Human Vaccines Market Forecast (2019-2030) 12.2.5 Middle East and Africa Human Vaccines Market Forecast (2019-2030) 12.3 Human Vaccines Market Forecast by Type (2019-2030) 12.3.1 Global Human Vaccines Sales Forecast by Type (2019-2030) 12.3.2 Global Human Vaccines Market Share Forecast by Type (2019-2030) 12.4 Human Vaccines Market Forecast by Application (2019-2030) 12.4.1 Global Human Vaccines Sales Forecast by Application (2019-2030) 12.4.2 Global Human Vaccines Market Share Forecast by Application (2019-2030) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

Key players profile in the report include
  • AstraZeneca
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Pfizer, Inc.
  • Sanofi
  • Johnson & Johnson

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS